Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment in paediatric sarcoma patients: A report from the Late Effects Surveillance System

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 687-691

  Paulides, Marios ^a   Stöhr, Wolfgang ^a   Bielack, Stefan ^b,c   Jürgens, Heribert ^b   Koscielniak, E W A ^c   Klingebiel, Thomas ^d   Zimmermann, Robert ^e   Stachel, Daniel ^a   Langer, Thorsten ^a   Beck, Jörn Dirk ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c OLGAHOSPITAL   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cancer; Hepatitis; Human immunodeficiency virus; Late effects; Transfusion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; AUSTRIA; CHILD; FEMALE; GERMANY; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; PROSPECTIVE STUDY; REGISTER; SARCOMA; STATISTICS; SWITZERLAND; VIRUS INFECTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; AUSTRIA; CHILD; FEMALE; GERMANY; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; REGISTRIES; SARCOMA; SWITZERLAND; VIRUS DISEASES;

EID: 33645729468     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.687     Document Type: Article

References (36)

1. Gigliotti AR, Fioredda F and Giacchino R: Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation. J Pediatr Hematol Oncol 25: 184-192, 2003. (Pubitemid 36292832)
2. Ceccherini-Nelli L, Filipponi F, Mosca F and Campa M: The risk of contracting an infectious disease from blood transfusion. Transplant Proc 36: 680-682, 2004. (Pubitemid 38534358)
3. Regan FA, Hewitt P, Barbara JA and Contreras M: Prospective investigation of transfusion transmitted infection in recipients of over 20,000 units of blood. TTI Study Group. BMJ 320: 403-406, 2000. (Pubitemid 30175768)
4. Sevinir B, Meral A, Gunay U, Ozkan T, Ozuysal S and Sinirtas M: Increased risk of chronic hepatitis in children with cancer. Med Pediatr Oncol 40: 104-110, 2003. (Pubitemid 35471374)
5. Fioredda F, Gigliotti AR, Haupt R, Calevo MG, Giudice CL, Bocciardo L and Giacchino R: HCV infection in very-long-term survivors after cancer chemotherapy and bone marrow transplantation: A single-center experience. J Pediatr Hematol Oncol 27: 481-485, 2005. (Pubitemid 41395901)
6. Strickland DK, Riely CA, Patrick CC, Jones-Wallace D, Boyett JM, Waters B, Fleckenstein JF, Dean PJ, Davila R, Caver TE and Hudson MM: Hepatitis C infection among survivors of childhood cancer. Blood 95: 3065-3070, 2000. (Pubitemid 30321155)
7. Kebudi R, Ayan I, Yilmaz G, Akici F, Gorgun O and Badur S: Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Med Pediatr Oncol 34: 102-105, 2000. (Pubitemid 30090473)
8. Castellino S, Lensing S, Riely C, Rai SN, Davila R, Hayden RT, Fleckenstein J, Levstik M, Taylor S, Dean PJ, Kippenbrock S, Pope J, Carr J, Strickland DK and Hudson MM: The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St. Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103: 2460-2466, 2004. (Pubitemid 38392994)
9. Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC, Rubnitz JE, Sandlund JT, Kun LE, Bowman LC, Razzouk BI, Mathew P, Shearer P, Evans WE and Pui CH: Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 18: 3273-3279, 2000.
10. Koltan S, Styczynski J, Wysocki M, Koltan A, Kurylak A and Debski R: Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years. Haematologica 89: 251-252, 2004. (Pubitemid 38796508)
11. Beck JD, Winkler K, Niethammer D, Brandis M, Hertzberg H, Von der HK, Greil J, Uberall MA, Lamprecht-Dinnesen A and Rossi R: After-care of children and young adults surviving cancer. Initial recommendations by the late sequelae study group. Klin Padiatr 207: 186-192, 1995.
12. Langer T, Henze G and Beck J: Basic methods and the developing structures of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany. Med Pediatr Oncol 34: 348-351, 2000. (Pubitemid 30230610)
13. Langer T, Stohr W, Bielack S, Paulussen M, Treuner J and Beck JD: Late effects surveillance system for sarcoma patients. Pediatr Blood Cancer 42: 373-379, 2004. (Pubitemid 38327633)
14. Langer T, Stohr W, Paulides M, Kremers A, Dorr HG, Gobel U and Beck JD: Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS). Klin Padiatr 217: 176-181, 2005. (Pubitemid 40705239)
15. Stohr W, Langer T, Kremers A, Brecht I, Treuner J, Dinnesen A and Beck JD: Hearing function in soft tissue sarcoma patients after treatment with carboplatin: a report from the Late Effects Surveillance System. Oncol Rep 12: 767-771, 2004.
16. Allain JP: Transfusion risks of yesterday and of today. Transfus Clin Biol 10: 1-5, 2003.
17. Offergeld R, Ritter S, Faensen D and Hamouda O: Report of the Robert Koch Institute according to Article 22 of the Transfusion Act for the years 2001 and 2002. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47: 1216-1229, 2004.
18. Stark K, Werner E, Seeger E, Offergeld R, Altmann D and Kramer MH: Infections with HIV, HBV, and HCV among blood donors in Germany 1998 and 1999. Infus Ther Transfus Med 29: 305-307, 2002. (Pubitemid 36005568)
19. Dellinger EP and Anaya DA: Infectious and immunologic consequences of blood transfusion. Crit Care 8 (Suppl 2): S18-S23, 2004. (Pubitemid 39144724)
20. Soldan K, Barbara JA, Ramsay ME and Hall AJ: Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 84: 274-286, 2003. (Pubitemid 36702334)
21. Soldan K, Davison K and Dow B: Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill 10: 17-19, 2005.
22. Pillonel J and Laperche S: Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill 10: 5-8, 2005.
23. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF and Sher G: Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 169: 767-773, 2003. (Pubitemid 37305113)
24. Alvarez do Barrio M, Gonzalez Diez R, Hernandez Sanchez J and Oyonarte Gomez S: Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing. Euro Surveill 10: 20-22, 2005.
25. Arora B, Joshi YK, Salhan RN, Arya LS and Prakash S: Transfusion- associated hepatitis in children with hematologic malignancies in Northern India. Med Pediatr Oncol 41: 166-168, 2003. (Pubitemid 36858344)
26. Hoshiyama A, Kimura A, Fujisawa T, Kage M and Kato H: Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 105: 62-65, 2000. (Pubitemid 30035719)
27. Schricker KT and Ehler R: Transfusion hepatitis in various operations (I). Med Welt 24: 999-1003, 1971.
28. Schricker KT and Ehler R: Transfusion hepatitis in various surgical operations (II). Med Welt 26: 1080-1083, 1971.
29. Tynell E, Norda R, Montgomery SM and Bjorkman A: Diagnosis and procedure-specific survival among transfusion of recipients in 1993 and 2000, Orebro County, Sweden. Vox Sang 88: 181-188, 2005. (Pubitemid 40516264)
30. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group. Transfus Med 4: 251-268, 1994.
31. Reesink HW: European strategies against the parasite transfusion risk. Transfus Clin Biol 12: 1-4, 2005.
32. Perrotta PL and Snyder EL: Non-infectious complications of transfusion therapy. Blood Rev 15: 69-83, 2001. (Pubitemid 32619560)
33. Wagner SJ: Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 86: 157-163, 2004.
34. Strong DM and Katz L: Blood-bank testing for infectious diseases: how safe is blood transfusion? Trends Mol Med 8: 355-358, 2002. (Pubitemid 34733391)
35. Sanchez R and Toy P: Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 45: 248-255, 2005. (Pubitemid 41077157)
36. Spiess BD: Risks of transfusion: outcome focus. Transfusion 44: S4-S14, 2004.